LECT2 and hepatocellular carcinoma: In the article titled “LECT2 Controls Inflammatory Monocytes to Constrain Growth and Progression of Hepatocellular Carcinoma”, the authors analyze how LECT2 influences the progression of HCC and suggest that LECT2 could be a beneficial immunotherapy choice for HCC.